Strategic biotech executive who is adept at building, inspiring and growing R&D and commercial organizations to achieve superior business results. Deep experience in developing company vision and leading businesses through all phases of biopharmaceutical product life-cycles with expertise in rare disease. Known for decisiveness, resilience, collaborative problem solving and relentless pursuit of delivering shareholder value while always keeping patients central in decision making.